AzTrials
AzTrials

Fetal Health AnxietyNCT07660393

The Use of Virtual Reality Glasses in Women With Premature Rupture of Membranes

A study testing Standard prenatal care and Nature-themed video in people with Fetal Health Anxiety and Prenatal Distress, run by Selcuk University at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The Effect of Virtual Reality Glass Use on Fetal Health Anxiety, Prenatal Distress, and Maternal-Fetal Attachment in Women with Premature Rupture of Membranes: A Randomized Controlled Trial Read more about this study

Who is it for?
Ages 18 to 50 years, women onlyHealthy volunteers can take part
What is being tested?
Standard prenatal care and Nature-themed video
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
176 participants
Where
1 siteTurkey (Türkiye)
Study dates
16 Jun 2026to 1 Jan 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Being 18 years of age or older
  • Being nulliparous
  • Having a diagnosis of preterm premature rupture of membranes (PPROM)
  • Being between 24 and 37 weeks of gestation
  • Having a singleton pregnancy
  • Being hospitalized in the ward for at least 3 days
Show all 9Show fewer
  • Having no visual or hearing impairment
  • Being communicative and mentally and psychologically healthy
  • Being able to speak and express oneself in Turkish

Who cannot join

  • Having an additional diagnosis besides preterm premature rupture of membranes (PPROM) (e.g., preeclampsia, fetal distress, fetal anomalies, gestational diabetes, bleeding, etc.)
  • Having a chronic disease (e.g., hypertension, diabetes mellitus, thyroid disorders, etc.)
  • Having conceived through assisted reproductive technologies (ART)
  • Having any skin infection.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Seyhan Çankaya, PhD contact

+905054300733

seyhane32@gmail.com

Seyhan Çankaya, PhD contact

+903322233577

sbf@selcuk.edu.tr

Turkey (Türkiye)1 site, 1 recruiting
  • Seyhan Çankaya

    Konya, 42250

    Seyhan Çankaya, PhD, 05054300733, seyhane32@gmail.com

    Seyhan Çankaya, PhD

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Virtual Reality Glass Use on Fetal Health Anxiety, Prenatal Distress, and Maternal-Fetal Attachment in Women With Premature Rupture of Membranes: A Randomized Controlled Trial

The Effect of Virtual Reality Glass Use on Fetal Health Anxiety, Prenatal Distress, and Maternal-Fetal Attachment in Women with Premature Rupture of Membranes: A Randomized Controlled Trial

Read the detailed description

This study is a randomized controlled trial. The study population will consist of nulliparous pregnant women hospitalized with a diagnosis of preterm premature rupture of membranes (PPROM) in the Perinatology Clinic of Konya City Hospital between June 2025 and January 2027. A total of 176 pregnant women who will be giving birth for the first time will be included in the study (intervention group: n = 88; control group: n = 88). In the intervention group, pregnant women with PPROM will watch a nature-themed video accompanied by natural sounds selected by the researchers through a virtual reality headset (VRH) twice daily for three consecutive days, with each session lasting at least five minutes. The control group will receive the standard antenatal care provided by the hospital. Data will be collected using a Personal Information Form, the Fetal Health Anxiety Scale, the Prenatal Distress Questionnaire, and the Prenatal Attachment Inventory.

Being tested
Standard prenatal care, Nature-themed video
Keywords
Virtual Reality Glasses (VRG), Fetal Health Anxiety, Prenatal Distress Scale, Prenatal Attachment

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Standard prenatal careOther

    The control group will receive standard prenatal care and treatment provided by the hospital.

    After the study is completed, control group participants will be shown nature-themed videos via Virtual Reality Glasses (VRG) if they wish.

  • Nature-themed videoOther

    Pregnant women with premise rupture of membranes (PRM) in the intervention group will be shown a nature-themed video prepared by the researchers with nature sounds via Virtual Reality Glasses (VRG) twice a day for at least five minutes each time for three days.

Study groups in NCT07660393
Study groupRoleWhat they receive
Standard prenatal carePlacebo comparatorThe control group will receive standard prenatal care and treatment provided by the hospital. After the study is completed, control group participants will be shown nature-themed videos via Virtual Reality Glasses (VRG) if they wish.
Receives: Other: Standard prenatal care; Other: Nature-themed video
Nature-themed videoExperimentalPregnant women with premise rupture of membranes (PRM) in the intervention group will be shown a nature-themed video prepared by the researchers with nature sounds via Virtual Reality Glasses (VRG) twice a day for at least five minutes each time for three days.
Receives: Other: Nature-themed video

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Comparison of sociodemographic characteristics of pregnant women with premature rupture of membranes prior to intervention using questionnaires.

    Sociodemographic information of pregnant women will be collected, compared, and reported through questionnaires.

    Measured: 6 months

  2. Comparison of mean scores on the Fetal Health Concern Scale among groups of pregnant women.

    The Fetal Health Concern Scale will be administered to pregnant women.

    The Fetal Health Concern Scale ranges from 0 to 42 points (minimum-maximum), with higher scores indicating greater fetal health concern.

    Measured: 6 months

  3. Comparison of mean Prenatal Distress Scale scores among groups of pregnant women.

    The Prenatal Distress Scale will be administered to all pregnant women.

    The Prenatal Distress Scale ranges from 0 to 34 points (minimum-maximum), with higher scores indicating greater prenatal distress.

    Measured: 6 months

  4. Comparison of mean Prenatal Attachment Inventory scores among groups of pregnant women.

    The Prenatal Attachment Inventory will be administered to all pregnant women.

    The Prenatal Attachment Inventory score ranges from 21 to 84 points (minimum-maximum), with higher scores indicating greater prenatal distress.

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jun 2026
  2. Study start16 Jun 2026
  3. Primary completion1 Jan 2027 (estimated)
  4. Study completion1 Jan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
176 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07660393
Sponsor's protocol ID
2025/1150
Status last verified
Aug 2026
First submitted
16 Jun 2026
Last updated
11 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Standard prenatal care and Nature-themed video in people with Fetal Health Anxiety and Prenatal Distress, run by Selcuk University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 11 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Seyhan Çankaya, PhD (+905054300733, seyhane32@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Comparison of sociodemographic characteristics of pregnant women with premature rupture of membranes prior to intervention using questionnaires. (time frame: 6 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in